Not logged in Relationships Between Insomnia and Quality of Life in Patients With Advanced Liver Cancer: A Secondary Analysis of a Multicenter Cross-Sectional Study Li, Zimeng; Song, Lili; Leng, Jiahua; Pang, Ying; He, Yi; Su, Zhongge; Wang, Yu; Zhou, Yuhe; Lu, Yongkui; Jiang, Yu; Han, Xinkun; Song, Lihua; Wang, Liping; Lv, Xiaojun; Wang, Yan; Yao, Juntao; Liu, Xiaohong; Zhou, Xiaoyi; He, Shuangzhi; Zhang, Yening; Li, Jinjiang; Wang, Bingmei; Tang, Lili Share Save
Novel TROP2 antibody-drug conjugates for treatment of HER2-negative metastatic breast cancer patients with brain metastases: a promising Wang, J.; Zhang, Y.; Bai, R.; Wu, Y.; Tong, Z.; Liu, A.; Zhang, Y.; Wang, H.; Wu, X.; Cheng, Y.; Yang, H.; Zhou, Q.; Xing, X.; Chen, X.; Qiu, F. Share Save
Share Save
Efficacy and safety of finotonlimab plus docetaxel vs. docetaxel in previously treated advanced squamous cell non-small-cell lung cancer: a randomized, double-blinded, phase III trial Han, Baohui; Wu, Lin; Yang, Runxiang; Wu, Hongbo; Li, Wei; Yu, Yan; Zhang, Mingjuan; Sun, Hongmei; Chu, Tianqing; Zhong, Fukuan; Fang, Yong; Wu, Rong; Bian, Tao; Guo, Xiaoqing; Sun, Meili; Zhang, Yanming; Liu, Lianke; Liu, Xuewen; Pan, Yueyin; Jiang, Ou; Wei, Zonghui; Lin, Haifeng; Guo, Wei; Fang, Jian; Wang, Jialei; Ding, Cuimin; Hu, Yanping; Ye, Feng; Zhuang, Wu; Ye, Shucheng; Wang, Lihong; Huang, Zhe; Liu, Chang; Yang, Ling; Wang, Jinling; Xie, Liangzhi Share Save
TRIM21-driven K63-linked ubiquitination of RBM38c, as a novel interactor of BECN1, contributes to DNA damage-induced autophagy Xia, Lishenglan; Xing, Yusheng; Ye, Xinjia; Wu, Yuanshun; Yang, Ying; Yin, Ziyi; Wang, Anni; Chen, Jian; Zhang, Min Share Save
Prevalence and concordance of HER2-low and HER2-ultralow status between historical and rescored results in a multicentre study of breast cancer patients in China Lv, Hong; Yue, Junqiu; Zhang, Qingfu; Xu, Fangping; Gao, Peng; Yang, Haifeng; Nie, Xiu; Kong, Lingfei; Zhang, Guanjun; Li, Jianming; Xiao, Shiwei; Wu, Hongmei; Xing, Aiyan; Hong, Min; Fan, Jun; Guan, Huijuan; Cao, Peilong; Ni, Hengli; Yang, Wentao Share Save
The impact of lymph node dissection on stage I ovarian endometrioid carcinoma: A US-China Comparative Analysis Sun, Meige; Lin, Fei; Shi, Jing; Wu, Xiang-Guang; Liang, Yunyi; Chen, Jialing; Gao, Qinglei; Yao, Shuzhong; Fan, Jiangtao; Chen, Youguo; Wang, Danbo; Huang, Yi; Fan, Liang-Sheng; Yang, Jun Share Save
Low versus high peripheral oxygen saturation directed oxygen therapy in critically ill patients: a multicenter randomized controlled trial Yang, Xiaobo; Gao, Xuehui; Zheng, Xiang; Zhao, Xu; Liu, Yanli; Zhang, Lu; Sun, Junli; Wang, Peng; Xu, Zhengqin; Hu, Ronghua; Li, Hongbin; Qi, Hong; Yuan, Yin; Chen, Wei; Liu, Jie; Huang, Guangqing; Yu, Li; Cao, Fengsheng; Xin, Keke; Yu, Min; Liu, Xiaoyun; Zhang, Li; Chang, Siyuan; Zou, Xiaojing; Liu, Hong; Fu, Zhaohui; Shu, Huaqing; Yu, Yuan; Xu, Jiqian; Yuan, Shiying; Shang, You Share Save
Anti-LAG-3 antibody LBL-007 plus anti-PD-1 antibody toripalimab in advanced nasopharyngeal carcinoma and other solid tumors: an open-label, multicenter, phase Ib/II trial Chen, Gang; Sun, Dong-Chen; Ba, Yi; Zhang, Ya-Xiong; Zhou, Ting; Zhao, Yuan-Yuan; Zhao, Hong-Yun; Fang, Wen-Feng; Huang, Yan; Wang, Zhen; Deng, Chao; Hu, De-Sheng; Wang, Wei; Lin, Jin-Guan; Li, Gui-Ling; Luo, Su-Xia; Fu, Zhi-Chao; Zhu, Hai-Sheng; Wang, Hui-Li; Cai, Sheng-Li; Kang, Xiao-Qiang; Zhang, Li; Yang, Yun-Peng Share Save
Prolgolimab with chemotherapy as first-line treatment for advanced non-squamous non-small-cell lung cancer Laktionov, K.; Smolin, A.; Stroyakovskiy, D.; Moiseenko, V.; Dvorkin, M.; Andabekov, T.; Cheng, Y.; Liu, B.; Kozlov, V.; Odintsova, S.; Dvoretsky, S.; Mochalova, A.; Urda, M.; Yi, T.; Li, X.; Laszlo, U.; Mueller, V.; Bogos, K.; Fadeeva, N.; Musaev, G.; Liu, Q.; Kirtbaya, D.; Shi, J.; Gladkov, O.; Narimanov, M.; Semiglazova, T.; Khasanova, A.; Chovanec, J.; Andrasina, I; Szabova, A.; Rosinska, O.; Sudekova, D.; Zsolt, P. -s.; Ran, F.; Sun, M.; Jiang, O.; Chen, R.; Zhao, E.; Liu, C.; Tan, W.; Pirmagomedov, A.; Poddubskaya, E.; Kislov, N.; Shumskaya, I.; Sorokina, I.; Zinkina-Orikhan, A.; Linkova, Yu.; Fogt, S.; Liaptseva, D.; Siliutina, A.; Basova, O.; Kryukov, F. Share Save
The practice and cost-effectiveness of opportunistic endoscopic screening for upper gastrointestinal tract cancer: a real-world study in China Sun, Kexin; Wang, Huadong; Qiao, Liang; Zhang, Nan; Zhang, Min; Yuan, Li; Jia, Shangchun; Huang, Wenkai; Zheng, Rongshou; Wei, Wenqiang; Wang, Guiqi Share Save
Updated efficacy and safety of SHR-A1811, an anti-HER2 antibody-drug conjugate, in heavily pretreated advanced solid tumors with HER2-expression or mutations: a global, multicenter, phase 1 study Yao, H.; Yan, M.; Tong, Z.; Wu, X.; Yin, Y.; Ryu, M. -h.; Park, J. J.; Dai, T.; Zhao, Y.; Kim, J. H.; Wang, S.; Zhong, Y.; Voskoboynik, M.; Zhang, J.; Kaubisch, A.; Liu, C.; Chen, Y.; Im, S. -a.; Wu, L.; Liu, Y.; Ganju, V.; Barve, M.; Li, H.; Yao, G.; Bao, L.; Teng, Y.; Qian, J.; Zhou, H.; Zhao, J.; Zhao, K.; Shen, Y.; Rong, S.; Zhu, X.; Song, E. Share Save
Lerociclib plus fulvestrant in patients with HR+/HER2-locally advanced or metastatic breast cancer who have progressed on prior endocrine therapy: LEONARDA-1 a phase III randomized trial Xu, Binghe; Zhang, Qingyuan; Luo, Yang; Tong, Zhongsheng; Sun, Tao; Shan, Changping; Liu, Xinlan; Yao, Yumin; Zhao, Bing; Wang, Shusen; Zeng, Xiaohua; Hu, Changlu; Yan, Xi; Wang, Xiaojia; Jia, Hongyan; Chen, Zhendong; Qiu, Fuming; Wu, Xinhong; Zhang, Deyong; Li, Tong Share Save
A phase II trial of anlotinib plus EGFR-TKIs in advanced non-small cell lung cancer with gradual, oligo, or potential progression after EGFR-TKIs treatment (CTONG-1803/ALTER-L001) Chen, Hua-Jun; Tu, Hai-Yan; Hu, Yanping; Fan, Yun; Wu, Guowu; Cang, Shundong; Yang, Yi; Yang, Nong; Ma, Rui; Jin, Gaowa; Xu, Ximing; Liu, Anwen; Tang, Shubin; Cheng, Ying; Yu, Yan; Xu, Chong-Rui; Zhou, Qing; Wu, Yi-Long Share Save
Study of conductive nerve conduits for anti-inflammatory and antioxidant effects Xu, Runtian; He, Hanping; Deng, Huan; Dong, Yuehan; Wu, Xiangjie; Xia, Zinuo; Zhou, Yang; Yang, Lin; Huang, Zhijun; Xu, Wenjin; Xu, Peihu; Xu, Haixing Share Save
Updated results of a phase II trial evaluating an anti-EpCAM x anti-CD3 bispecific antibody, M701, for the treatment of malignant ascites Liu, R.; Xu, J.; Lin, R.; Li, N.; Li, G.; Zhang, T.; Zhao, J.; Li, J.; Sun, M.; Wang, K.; An, H.; Zhang, W.; Xu, H.; Zeng, S.; Zhang, M.; Zhou, P.; Huang, S.; Wang, X. Share Save
Asia subgroup overall survival and long-term follow-up results of the phase IIb HERIZON-BTC-01 study: Zanidatamab in previously treated human epidermal growth factor receptor 2 (HER2)-amplified biliary tract cancer (BTC) Oh, D-Y.; Sun, H.; Kim, J. W.; Choi, H. J.; Chang, H-M.; Bao, L.; Ying, J.; Xie, F.; Lee, M. A.; Seol, Y. M.; Wu, X.; Bao, Y.; Garfin, P.; Zhao, Y.; Fan, J. Share Save
Real-world treatment (Tx) patterns in patients (pts) with HER2-positive locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma (HER2+aGC/GEJC) in East Asia (HER2+GASTA) Oh, D-Y.; Yeo, W.; Chen, J-S.; Ba, Y.; Chan, W. W. L.; Chen, M-J.; Chen, Y. H.; Gu, K.; Hung, Y-P.; Kim, J. G.; Lee, J.; Liang, X.; Luo, S.; Rha, S. Y.; Yuan, Y.; Kim, T.; Yanagida, M.; Sato, R.; Xu, R-H. Share Save
A phase II study of Becotatug (JMT101) in combination with osimertinib (Osi) in patients (pts) with classical EGFR-mutated non-small cell lung cancer (NSCLC) (BOOSTER Study) Zhang, L.; Fang, W. F.; Zhao, S.; Yu, Y.; Yong, T. X.; Dong, X.; Zhuang, W.; Hu, Y.; Luo, F.; Wang, Q.; Chu, Q.; Fu, Z.; Yao, Y.; Ma, X.; Ding, C.; Hao, J.; Yang, X.; Wan, X.; Li, M.; Yang, Y. Share Save
Perioperative nivolumab (NIVO) in patients (pts) with resectable stage IIeIIIB NSCLC: CheckMate 77T Chinese population analysis He, J.; Wu, L.; Gao, Y.; Ying, K.; Jiang, G.; Lee, K-Y.; Chen, C.; Zhong, H.; Liu, S.; Xiong, F.; Chen, K-N.; Liu, L.; Tan, L.; Wang, W.; Shih, J-Y.; Sun, H.; Kang, W.; Zhang, H.; Lu, S. Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
